-
2022-502777-42-00
5
Hypercholesterolemia
-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2023-504035-40-00
4
Patients with pre neoplastic high grade HPV-related vulvar and cervica
-
2023-509392-17-00
5
Relapsed Acute Lymphoblastic Leukemia (ALL)
-
2024-513724-42-00
10
Medulloblastoma
-
2024-515439-31-00
5
Alopecia areata
-
2024-515448-22-00
4
Parkinson
-
2024-515555-38-01
4
NON SMALL CELL LUNG CANCER
-
2024-517796-21-00
5
Prevention of recurrence after a first episode of Venous Thromboemboli
-
2024-517861-18-00
5
Idiopathic IgA nephropathy (IgAN)
-
2024-518013-25-00
4
Idiopathic Pulmonary Fibrosis
-
2024-518225-15-00
4
Myelofibrosis
-
2024-518420-80-00
5
Primary infection prophylaxis for secondary immunodeficiency (SID) in
-
2024-519106-12-00
4
Patients with anaplastic lymphoma kinase positive (ALK+) locally advan
-
2024-519519-32-00
4
urothelial cancer
-
2024-519818-31-01
5
Endometrial Cancer
Advanced, Recurrent, Metastatic, or Primary Unresec
-
2024-520326-11-00
4
Acute Myeloid Leukemia (AML)
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-521209-42-00
6
advanced colorectal cancer with wild-type RAS and right primary tumour
-
2025-521221-32-00
5
Advanced or Metastatic Non-Small Cell Lung Cancer
-
2025-521587-35-00
5
Metastatic colorectal cancer
-
2025-521590-13-00
5
Moderately to Severely Active Crohn’s Disease
-
2025-521666-10-01
4
Mantle Cell Lymphoma
-
2025-521671-31-00
9
Relapsed/Refractory (R/R) and Minimal Residual Disease Positive (MRD+)